John P. Leonard, an expert in lymphoma and other blood cancers, was named director of the Center for Blood Cancers and chief of the Division of Hematology and Medical Oncology in NYU Grossman School of Medicine’s Department of Medicine. The Division of Hematology and Medical Oncology is a major clinical arm of the Perlmutter Cancer Center.
Michael Byrne, a malignant hematologist at Tennessee Oncology, was named medical director for cellular therapy at OneOncology.
Arjan Gower, a hematologist/oncologist at the UCLA Health Jonsson Comprehensive Cancer Center, received a $950,000 grant from the National Comprehensive Cancer Network and Taiho Oncology Inc. to help launch a multi-institutional clinical trial to test zipalertinib, an investigational drug that targets specific EGFR mutations, including Exon 20 insertions, which are known to drive cancer growth and resist standard treatments.
The Robert A. Winn Clinical Investigator Pathway Program, a national program administered by VCU Massey Comprehensive Cancer Center, officially launched its fourth annual cohort.
The American Society for Radiation Oncology selected 43 members to receive the ASTRO Fellow designation this year. Fellows are chosen for their achievements and contributions to ASTRO, cancer research, education, patient care, and the specialty of radiation oncology.
The Multinational Association of Supportive Care in Cancer announced its inaugural cohort of MASCC Fellows at its 2025 annual meeting.
Breast medical oncologist and cancer survivorship expert Neil M. Iyengar was appointed director of survivorship services at Winship Cancer Institute of Emory University.
Besim Ogretmen was named assistant vice president for research in the Office of the Vice President for Research at the Medical University of South Carolina.
Florida Cancer Specialists & Research Institute, LLC has been awarded two grants by the Florida Cancer Innovation Fund.
The Hebrew University of Jerusalem and Georgetown University have established a joint initiative on cancer to amplify innovation, discovery and action to end the disease.
